Human Papilloma Virus (HPV) vaccine was being implemented by OCDI, in partnership with the International Vaccine Access (IVAC), Direct Consulting and Logistics (DCL), National Primary Health Care Development Agency (NPHCDA), and Women Advocate for Vaccine Access (WAVA), with funding from Gavi, through John Hopkins Univeristy.